Raymond Bergan
Deputy Director of the Fred & Pamela Buffett Cancer Center and Bill Bures and Jerry Pabst Chair in Cancer Research at UNMC · University of Nebraska Medical Center College of Medicine
Credentials: · · · ·
History
PresentFred & Pamela Buffett Cancer Center and Bill Bures and Jerry Pabst Chair in Cancer Research at UNMC · University of Nebraska Medical Center College of Medicine
- Present
- Present
Fred & Pamela Buffett Cancer Center · University of Nebraska Medical Center College of Medicine
- 1990–1992
Medical Oncology
- 1987–1990
Internal Medicine
Research
Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer
Oncotarget · 2016 · 303 citations
Circulating giant macrophages as a potential biomarker of solid tumors
Proceedings of the National Academy of Sciences of the United States of America · 2014 · 226 citations
Oncogene · 2006 · Last of 3 authors · 172 citations
William Figg
11 papers
- ER
8 papers
8 papers
6 papers
6 papers
- AG
5 papers
- CC
5 papers
- GT
5 papers
Grants
- 2023–2028
Preventing Invasive Prostate Cancer
National Cancer Institute · R01
Contact PI · $2.9M · State University New York Stony Brook
- 2026–2027
Dual Acting Bone Defenders for Inhibiting Cancer Mediated Bone Destruction
National Cancer Institute · R42
Contact PI · $400K · Bonestrong Therapeutics Inc.
- 1997–2022
National Cancer Institute · P30
Project lead · $239.8K · Oregon Health & Science University
- 2015–2020
National Cancer Institute · P50
Project lead · $254.4K · Northwestern University
Clinical trials
- 2011–2014
Principal investigator · Completed · Phase 1
National Cancer Institute (NCI)
- 2007–2009
Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy Patients
Principal investigator · Completed · Phase 1
National Cancer Institute (NCI)
- 2002–2009
Study chair · Terminated · Phase 2
Northwestern University
- 2000–2004
Oltipraz in the Prevention of Lung Cancer in People Who Smoke
Study chair · Completed · Phase 1
Northwestern University